drugset / Trial / NCT02363075
Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to estimate the efficiency at 3 months of dexamfetamine sulphate on the MFI 20 scale in severe fatigue of patients with stabilized gliomas.
Timeline
- Start
- 2013-04
- Primary completion
- 2017-07
- Completion
- 2018-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextroamphetamine | Small molecule | 30 mg | Oral |